As a result of scientific and technological advances of the past decade, AIDS is now considered as a chronic disease. The great benefit generated by the use of antiretroviral therapy is the prolongation of survival and reduction in mortality, however, the adverse effects associated with this therapy may cause changes in quality of life. Such advances, however, are faced with new challenges today, among them stand adherence to antiretroviral therapy, as its use must be continuous and duradouro.Este study aims to assess adherence to antiretroviral therapy for people living with HIV / AIDS, using the CEAT-HIV. It is an analytical, cross-sectional, which will be held in services specializing in the care of people living with HIV / AIDS, in Ribeirão Preto-SP. For data collection will be used oo CEAT-HIV, as well as a tool for the characterization of participants. This project aims to contribute to the advancement of knowledge about the sociodemographic, clinical, epidemiological, and adherence to antiretroviral therapy for people living with HIV / AIDS and possible improvement actions / interventions in the comprehensive health care of these individuals.
News published in Agência FAPESP Newsletter about the scholarship: